ChatGPT

Perplexity

Gemini

Claude

Grok

Welcome to ABC Order HS Mobile! ABC Order HS Mobile integrates with AmerisourceBergen's new customer platform, ABC Order HS.
ABC Order HS Mobile enables you to:
- Scan barcodes
- Work with your orders

Welcome to ABC Order Mobile!  ABC Order Mobile fully integrates with AmerisourceBergen's customer platform, ABC Order.  

ABC Order Mobile enables you to:

- Scan barcodes
- Work with your carts 
- Se

Cencora prioritizes the well-being and success of its team members, customers, and patients. The company fosters an environment that drives connection to their purpose and the positive impact they have on society.

Put People First

The company cultivates an inclusive workplace where everyone feels valued and empowered to be their true selves. Cencora's commitment to diversity and inclusion has earned recognition as a top workplace for four consecutive years.

Celebrate Individuality

Collaboration and teamwork are fundamental to Cencora's approach. The company emphasizes working together across global teams to deliver integrated solutions that serve the entire healthcare ecosystem.

Act Together

Honesty, transparency, and integrity guide all of Cencora's interactions with stakeholders. The company maintains open communication and ethical business practices across all operations.

Tell the Truth

Speed and responsiveness are critical in healthcare. Cencora values timely communication and rapid action to ensure patients receive the medications and care they need without delay.

Tell It Fast

Cencora team members are empowered to identify challenges and contribute innovative solutions. The company encourages proactive problem-solving and continuous improvement across all functions.

Be Part of the Solution

Cencora is one of the world's largest pharmaceutical distribution and healthcare services companies, providing comprehensive drug distribution, specialty pharmaceutical services, commercialization support, and clinical logistics to healthcare providers globally. With operations in over 50 countries and annual revenue exceeding $316 billion, Cencora connects manufacturers, pharmacies, and healthcare providers to ensure patients receive the medications they need.

Cencora makes $1B investment in pharma supply chains

Cencora says additional data stolen in February cyberattack

Cencora reports data exfiltration in cyberattack on pharmaceutical giant

Robert P. Mauch

President & Chief Executive Officer

Steven H. Collis

Executive Chairman

James F. Cleary

Executive Vice President & Chief Financial Officer

Francois Mandeville

Executive Vice President, Strategy and M&A

Pawan Verma

Executive Vice President, Chief Data and Information Officer

Juan Guerra

Executive Vice President & President of International Business Group

Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale and distribution company and a contract research organization, that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. It was renamed to Cencora in 2023. Cencora is one of the largest pharmaceutical companies in the world and distributes generic pharmaceuticals, over-the-counter healthcare products, as well as home healthcare supplies and equipment.

Comprehensive distribution of brand-name and generic pharmaceuticals, over-the-counter healthcare products, and home healthcare supplies to acute care hospitals, health systems, independent and chain retail pharmacies, mail-order facilities, physicians, clinics, nursing homes, and assisted living centers. Cencora operates 26 distribution centers in the U.S. and supplies approximately one-third of the domestic drug distribution market.

Pharmaceutical Wholesale Distribution

Leading specialty pharmaceutical distribution and services for advanced therapies including cell and gene therapies, biosimilars, and specialty medicines. Cencora operates three U.S. facilities dedicated exclusively to specialty medicines and provides comprehensive support for complex, high-cost medications requiring special handling and patient support.

Specialty Pharmaceutical Services

Holistic pharmaceutical services combining data, analytics, and support to help manufacturers accelerate time-to-market, reduce risk, and optimize the patient journey. Services include market access strategy, reimbursement support, distribution planning, and launch execution for new pharmaceutical products.

Commercialization Support Services

Premium pharmaceutical storage and transportation solutions for safe, compliant transport with state-of-the-art climate control systems. Includes World Courier's global clinical trial logistics services, providing specialized handling for investigational products and temperature-sensitive medications.

Specialty Logistics and Transportation

Comprehensive suite of pharma patient support services designed to address potential barriers to access and increase speed-to-therapy. Includes copay assistance programs, patient education, adherence support, and specialty pharmacy services to improve patient outcomes.

Patient Support Services

European pharmaceutical distribution network serving over 110,000 points of care across 11 countries. Provides wholesale distribution, pharmacy services, and manufacturer solutions throughout Europe, significantly extending Cencora's global reach.

Alliance Healthcare International Distribution

Management services for retina specialists through Retina Consultants of America (RCA), acquired in January 2025. Provides practice management, clinical support, and integrated care solutions for physician-administered retina treatments, advancing Cencora's specialty care capabilities.

Retina Specialty Care Management

Cencora announced the completion of its acquisition of approximately 85% interest in Retina Consultants of America (RCA) for $4.4 billion in cash, subject to post-closing adjustments. RCA is a leading management services organization of retina specialists, and the acquisition advances Cencora's specialty leadership in physician-administered treatments. Certain RCA physicians and members of the management team retained a minority equity interest in the company. The acquisition was financed through a $1.8 billion senior notes offering and existing cash resources.

Cencora Completes Acquisition of Retina Consultants of America

Cencora reported fiscal 2025 first quarter results with revenue of $81.5 billion, marking a significant 12.8% increase compared to the same period last year. The company raised its fiscal 2025 adjusted EPS guidance to $15.70-$15.95 from the previous $15.30-$15.60, supported by the January 2025 acquisition of Retina Consultants of America and increased sales of diabetes and weight loss products in the GLP-1 class. The strong performance demonstrates continued growth across pharmaceutical distribution and specialty services segments.

Cencora Reports Strong Fiscal 2025 First Quarter Results

Cencora announced the appointment of Francois Mandeville as Executive Vice President, Strategy and M&A, and Pawan Verma as Executive Vice President, Chief Data and Information Officer. These strategic appointments strengthen Cencora's executive leadership capabilities in mergers and acquisitions strategy and digital transformation. Mandeville will lead strategic planning and M&A activities, while Verma will oversee data strategy, information technology infrastructure, and analytics initiatives critical to the company's continued innovation and growth.

Cencora Expands Enterprise Leadership Team with Two Senior Appointments

Cencora entered into a definitive agreement to acquire Retina Consultants of America (RCA) from Webster Equity Partners for $4.6 billion, with potential contingent consideration of up to $500 million in fiscal years 2027 and 2028. RCA is a leading management services organization providing comprehensive support to retina specialists across the United States. The acquisition extends Cencora's specialty pharmaceutical capabilities into physician-administered treatments and retina care, a rapidly growing segment of specialty medicine. The transaction closed in January 2025.

Cencora Advances Specialty Leadership Through $4.6 Billion Acquisition of Retina Consultants of America

Cencora closed a public offering of $1.8 billion in senior notes, including $500 million of 4.625% Senior Notes due December 15, 2027, $600 million of 4.850% Senior Notes due December 15, 2029, and $700 million of 5.150% Senior Notes due February 15, 2035. The proceeds were used to finance the acquisition of Retina Consultants of America and related fees and expenses, as well as for general corporate purposes. The successful offering demonstrates strong investor confidence in Cencora's strategic growth initiatives and financial strength.

Cencora Closes $1.8 Billion Senior Notes Offering

Cencora won four Gold awards in 2024 including 'Best Corporate Culture Transformation,' 'Best HR Strategy and Measurement Approach,' 'Best Learning Measurement,' and 'Best Program for Measuring Diversity, Equity, Inclusion and Belonging.' The awards recognize Cencora's commitment to fostering an inclusive workplace culture where team members feel valued and empowered. The recognition reflects the company's successful cultural integration following the 2023 rebranding from AmerisourceBergen to Cencora and its ongoing commitment to diversity, equity, and inclusion initiatives.

Cencora and Handcrafted Learning Win Four Gold Awards for Global Culture Transformation

Cencora reported fiscal year 2024 revenue of $294.0 billion, representing a 12.1% increase from the prior year, with adjusted diluted EPS increasing 14.8% to $13.76. The company managed a gross profit of $11.5 billion, a notable improvement from the previous year's $9.9 billion. The strong financial performance was driven by growth in specialty pharmaceutical distribution, international expansion through Alliance Healthcare, and increased demand for GLP-1 medications and biosimilars. The results demonstrate Cencora's successful execution of its strategic growth initiatives.

Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results

Cencora/The Lash Group - Data Security Incident Settlement

Cencora acquiring EyeSouth Partners' retina business for $1.1B

Cencora Interview--Signal App

Thoughts on Amerisource Bergen (now Cencora) or Cardinal?

[Interview Experience] Cencora panel interview – unprofessional, felt like hazing

Anyone file the cencora settlement?

Cencora Alliance Healthcare

Cencora, Inc. Annual Report Released - Here’s What You Should Know

Question for Cencora warehouse associates

ClassActionSettlement

pharmacy

Ophthalmology

WFHJobs

recruitinghell

uktrucking

SECFilingsAI

Cencora, Inc.

Wholesale-Drugs, Proprietaries & Druggists' Sundries

AmeriSource Health Corporation and Bergen Brunswig Corporation completed their merger on August 29, 2001, creating AmerisourceBergen with approximately $36 billion in annualized operating revenues, becoming a leader in U.S. pharmaceutical services.

Company Founded Through Merger

AmerisourceBergen was added to the S&P 500 index, reflecting its significant market capitalization and importance in the pharmaceutical distribution industry.

Added to S&P 500 Index

Steven H. Collis was promoted to CEO, beginning a transformative period of growth that would see annual revenue triple from $80 billion to over $250 billion during his tenure.

Steven H. Collis Becomes CEO

AmerisourceBergen acquired World Courier Group Inc for $520 million, adding premier global specialty transportation, storage, and distribution services for clinical trials.

Acquired World Courier Group

The company acquired MWI Veterinary Supply for $2.5 billion, expanding into veterinary pharmaceutical distribution and diversifying revenue streams beyond human healthcare.

Acquired MWI Veterinary Supply

AmerisourceBergen agreed to acquire PharMEDium for $2.58 billion, significantly expanding its capabilities in pharmacy compounding and sterile medication preparation.

Acquired PharMEDium

On January 3, 2018, AmerisourceBergen acquired H.D. Smith, the largest privately held national pharmaceutical wholesaler in the United States, expanding distribution capabilities and market share.

Acquired H.D. Smith

AmerisourceBergen acquired Alliance Healthcare from Walgreens Boots Alliance for approximately $6.5 billion, significantly extending distribution presence across 11 European countries and serving over 110,000 points of care. The acquisition marked a major global expansion milestone.

Acquired Alliance Healthcare

On August 30, 2023, AmerisourceBergen changed its name to Cencora and began trading on the New York Stock Exchange under the new ticker symbol 'COR,' unifying 46,000 employees across global business segments under one identity.

Rebranded as Cencora

Cencora announced that Steven H. Collis would retire as President and CEO effective October 1, 2024, transitioning to Executive Chairman, with Robert P. Mauch promoted to President and CEO.

Announced Leadership Succession Plan

Dr. Robert P. Mauch assumed the role of President and CEO on October 1, 2024, becoming the third CEO in Cencora's 23-year history and leading the company's next phase of growth and innovation.

Robert P. Mauch Becomes CEO

Cencora entered into a definitive agreement to acquire Retina Consultants of America (RCA), a leading management services organization of retina specialists, from Webster Equity Partners for $4.6 billion, with potential contingent consideration of up to $500 million.

Announced Acquisition of Retina Consultants of America

Cencora appointed Francois Mandeville as EVP of Strategy and M&A, and Pawan Verma as EVP and Chief Data and Information Officer, strengthening executive capabilities in strategic growth and digital transformation.

Expanded Enterprise Leadership Team

Cencora closed a public offering of $1.8 billion in senior notes, including notes due in 2027, 2029, and 2035, to finance the Retina Consultants of America acquisition and general corporate purposes.

Closed $1.8 Billion Senior Notes Offering

Cencora completed its acquisition of approximately 85% interest in Retina Consultants of America for $4.4 billion in cash, with certain RCA physicians and management retaining minority equity. The acquisition advances Cencora's specialty leadership in physician-administered treatments.

Completed Retina Consultants of America Acquisition

Explore the latest styles in fashion, home and beauty with the H&M app. Discover inspiring collections and intuitive features that simplify the shopping experience — from instant search to real-time o

Your top app for online fashion shopping in Saudi Arabia, United Arab Emirates, Kuwait, Egypt, and Qatar.  Download the H&M app and shop all fashion clothing and accessories such as:

- Women's clothe

Erling Persson (1947 Sweden, retail entrepreneur)

Germany fines H&M 35 million euros for data protection breaches

H & M Hennes & Mauritz AB, commonly known by its brand name H&M, is a Swedish multinational clothing company headquartered in Stockholm. Built on a fast fashion business model, the retailer sells apparel, accessories, and homeware. The company operates thousands of stores across 75 geographical markets and employs over 171,000 people worldwide. H&M is the second-largest international clothing retailer after Inditex. H&M was founded by Erling Persson in 1947 under the name Hennes. The CEO of H&M from 2020 to 2024 was Helena Helmersson. The current CEO, as of January 2024, is Daniel Ervér.

Swedish multinational clothing-retail company

H&M generated $22B revenue 2024 as 2nd-largest fashion retailer (Swedish privately-held Persson family, 4,000+ stores 75 countries down from 5,000 peak, fast-fashion $10-40 T-shirts/dresses/basics, Conscious Collection sustainability 50% recycled). Founded 1947 Sweden as Hennes ('Hers') by Erling Persson (women's clothing, 1968 acquired Mauritz Widforss menswear rebranded H&M). 1970s-2000s global (U.S. 2000 NYC, 3,000+ stores, designer collaborations Karl Lagerfeld 2004 $100M sellout). However, 2015-2024 struggles: inventory crisis $4B unsold 2018 (slow fashion cycles versus Zara 2-week, store closures 500+, online 30% transition late), sustainability backlash greenwashing allegations Conscious Collection 5% actually recycled, Shein $30B ultra-fast $5-15 Gen Z. Competing Zara $30B #1 Inditex, Uniqlo $20B basics, Shein $30B online-only $5. Technology: mobile app, membership loyalty, digital receipts, inventory AI predictive limited. Employees 100,000+ (from 120K peak, store closures layoffs).

H&M's Sustainability Push and Inventory Crisis Navigate Fast-Fashion Backlash as Zara Competition and Shein $30B Ultra-Fast Threaten Market Share

H&M reaches $22B revenue as 2nd-largest global fashion retailer with 4,000+ stores, fast-fashion $10-40 model, Swedish origins, struggling Zara competition

H&M HENNES & MAURITZ AB

Women's clothing 'Hers'. Affordable fashion U.S.-inspired. 15 stores Sweden expansion.

Hennes & Mauritz. Added men's hunting/outdoor apparel. Stockholm stock. Sweden national chain.

Fifth Avenue flagship. 3,000+ stores. Fast-fashion model 2-4 week cycles. Zara competition began.

Stella McCartney, Balmain, Versace collabs. Prestige affordable $50-100. Marketing hype lines.

Recycled materials 50% claim. Greenwashing allegations 5% actually recycled. Garment collecting stores.

Slow fashion cycles vs Zara 2-week. Online 30% late transition. Shein $30B $5-15 Gen Z ultra-fast threat.

CEO Helena Helmersson sustainability. Persson family billionaires privately-held. 100K employees (from 120K). Online 30%.

Cencora vs H&M (Hennes & Mauritz)

Cencora

About

H&M (Hennes & Mauritz)

About

AI Visibility Head-to-Head

Also Compare

Track AI Visibility in Real Time